Actionable news
All posts from Actionable news
Actionable news in PTCT: PTC Therapeutics, Inc.,

PTC Therapeutics Spikes 40% After Translarna Update In England

Invest with Confidence. Are you a financial professional? Stay on top of your portfolio with Benzinga Pro's real-time newsfeed and alerts and never miss a headline again.
Don't miss the chance to try it FREE today.

Shares of PTC Therapeutics, Inc. PTCT 42.86%, a biopharmaceutical company that focuses on therapeutics that target post-transcriptional control processes, surged higher by more than 40 percent Friday afternoon.

Investors and traders were reacting to the company's announcement that the England-based National Institute for Health and Care Excellence (NICE) has recommended the company's Translarna (ataluren) for ambulatory patients that suffer from nonsense mutation Duchenne muscular dystrophy (nmDMD).

Translarna was...